Company Filing History:
Years Active: 2003-2011
Title: **Anil Kumar Rastogi: Pioneer in Pharmaceutical Innovations**
Introduction
Anil Kumar Rastogi, a prominent inventor based in Lucknow, India, has made significant contributions to the field of pharmaceuticals. With a robust portfolio of six patents, his work primarily focuses on innovative solutions for health-related issues, particularly in the treatment of diabetes and dyslipidemia.
Latest Patents
Among his latest patents, Rastogi has developed a pharmaceutical composition that provides a bioactive fraction useful for the treatment of diabetes and dyslipidemia. This composition serves as both an antidiabetic and antidyslipidemic agent, showcasing its potential effectiveness for the management of these conditions. Additionally, he has innovated methods for preparing bioactive fractions, focusing on isomeric xyloccensins and their therapeutic applications. His research includes a novel saponin, tigogenin penta glycoside, isolated from the aerial parts of specific plants, which has demonstrated promising anti-hyperglycemic and hypolipidemic activities.
Career Highlights
Anil Kumar Rastogi is affiliated with the Council of Scientific & Industrial Research, a leading research organization in India. His role involves pioneering research in pharmaceutical formulations, aiming to improve the quality of life for patients suffering from metabolic disorders. His various patents reflect his commitment to addressing pressing health issues through scientific innovation.
Collaborations
Throughout his career, Rastogi has collaborated with notable colleagues, including Arvind Kumar Srivastava and Deepak Raina. These partnerships have enriched his research endeavors, allowing for a diverse exchange of ideas and expertise that enhances the quality and impact of his work.
Conclusion
Anil Kumar Rastogi stands out as a dedicated inventor whose work is driving advancements in pharmaceutical science. His contributions not only illustrate the significance of innovation in healthcare but also highlight the importance of collaborative efforts in achieving groundbreaking solutions for contemporary medical challenges. Through his patents and ongoing research, Rastogi continues to pave the way for future advancements in the treatment of diabetes and dyslipidemia.